Media/Policy Watch

Media/Policy Watch
This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.
We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.

 

The Atlantic
http://www.theatlantic.com/magazine/
Accessed 15 Aug 2020
The Plan That Could Give Us Our Lives Back
The U.S. has never had enough coronavirus tests. Now a group of epidemiologists, economists, and dreamers is plotting a new strategy to defeat the virus, even before a vaccine is found.
Story by Robinson Meyer and Alexis C. Madrigal
August 14, 2020

 

BBC
http://www.bbc.co.uk/
Accessed 15 Aug 2020
Coronavirus: Russia calls international concern over vaccine ‘groundless’
12 August 2020

 

The Economist
http://www.economist.com/
Accessed 15 Aug 2020
The Intelligence
“It would make sense to spend as much as $200bn on bringing forward a vaccine by just one week”

 

Financial Times
http://www.ft.com/home/uk
Accessed 15 Aug 2020
[No new, unique, relevant content]

 

Forbes
http://www.forbes.com/
Accessed 15 Aug 2020
Editors’ Pick  |  
10 hours ago
How Long Are You Immune After Covid-19 Coronavirus? Here Is What CDC Says
The Centers for Disease Control and Prevention (CDC) has some new guidance about whether you should get tested for SARS-CoV2 or quarantine after recovering from Covid-19.
By Bruce Y. Lee Senior Contributor

Aug 14, 2020
Lessons From The Frontlines: Preparing A Global Vaccine Workforce
Ashoka talks to Dr. Sanjeev Arora, founder of Project ECHO, on the challenge ahead: readying a multi-million-person vaccine workforce in as little as seven months.
By Ashoka Contributor

Aug 14, 2020
Valuing Innovative Drugs Based On Their Cost Of Manufacturing Will Prolong The Covid-19 Pandemic
The myth that an innovative drug’s value can be assessed by counting up its cost of production is dangerous. In reality, the value of an innovative drug is derived from the new practical knowledge created, and how that knowledge benefits patients.
By Wayne Winegarden Contributor

 

Foreign Affairs
http://www.foreignaffairs.com/
Accessed 15 Aug 2020
Essay September/October 2020
The Tragedy of Vaccine Nationalism
Global cooperation on vaccine allocation would be the most efficient way to disrupt the spread of the virus
Thomas J. Bollyky and Chad P. Bown

 

Foreign Policy
http://foreignpolicy.com/
Accessed 15 Aug 2020 |
[No new, unique, relevant content]

 

The Guardian
http://www.guardiannews.com/
Jeremy Farrar: ‘Viruses know no borders. Until every country is protected, we are all at risk’
Jeremy Farrar
Fri 14 Aug 2020
There is no future in narrow nationalism. The only way out of this crisis is by working together

 

New Yorker
http://www.newyorker.com/
Accessed 15 Aug 2020
Daily Comment
The Case for a Coronavirus-Vaccine Bond
Is financial engineering the key to ending pandemics?
By Bernard Avishai

 

New York Times
http://www.nytimes.com/
Accessed 15 Aug 2020
Middle East
UAE, Israeli Companies Sign ‘Strategic Commercial Agreement’ on Coronavirus R&D
The Emirati APEX National Investment company signed a “strategic commercial agreement” with Israel’s Tera Group to cooperate on research and development related to COVID-19, including a testing device, the UAE’s state news agency WAM said late on Saturday.
By Reuters Aug 15

Americas
Coronavirus Crisis Has Made Brazil an Ideal Vaccine Laboratory
Widespread contagion, a deep bench of scientists and a robust vaccine-making infrastructure have made Brazil an important player in the quest to find a vaccine.
By Manuela Andreoni and Ernesto Londoño
Aug 15

Asia Pacific
Modi Says India Set to Mass Produce COVID-19 Vaccine, Launches Digital Health Mission
India is ready to mass produce COVID-19 vaccines when scientists give the go-ahead, Prime Minister Narendra Modi said in his Independence Day speech on Saturday, also launching a national project to roll out health identities for each citizen.
By Reuters Aug 14

Americas
Argentine Firm Behind AstraZeneca COVID Vaccine Latam Production Sees April/May Launch
The Argentine biotech firm working on the production of 400 million doses of an AstraZeneca COVID-19 vaccine for Latin America said on Friday it could begin shipping the active substance of the product to Mexico for completion.
By Reuters Aug 14

U.S.
Vaccine Makers Including Moderna Must Hit U.S. Timing Goals for Full Payments
The United States is tying payments for COVID-19 vaccines to timing milestones for production and approval, according to public documents and a Trump administration official, putting pressure on drugmakers including Moderna Inc to meet ambitious targets.
By Reuters Aug 14

U.S.
As COVID-19 Cases Rise in U.S., Precious Plasma Donations Lag
In late April, a coalition of New Mexico healthcare systems began asking local COVID-19 survivors to donate their plasma, the antibody-rich blood product used to help treat people hospitalized with the disease.
By Reuters Aug 14

Europe
Russian Doctors Wary of Rapidly Approved COVID-19 Vaccine, Survey Shows
A majority of Russian doctors would not feel comfortable being injected with Russia’s new COVID-19 vaccine due to the lack of sufficient data about it and its super-fast approval, a survey of more than 3,000 medical professionals showed on Friday.
By Reuters Aug 14

 

Washington Post
https://www.washingtonpost.com/
Accessed 15 Aug 2020
CDC asks 4 states and a city to draft coronavirus vaccine distribution plans
The federal government is asking four states and one city to draft plans for how they would distribute a coronavirus vaccine when limited doses become available, possibly as early as this fall.
The Centers for Disease Control and Prevention, the Defense Department and other agencies began working with officials in California, Florida, Minnesota, North Dakota and Philadelphia this week to develop plans to transport and store vaccine doses, and to prioritize who would receive them…
Lena H. Sun and Brady Dennis · Aug 14, 2020